Related Experiment Video
Updated: Feb 28, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Prolonged antibiotic treatment for infected low flow vascular malformations
Katy M Wagner1, Zerina Lokmic2, Anthony J Penington2
1The Royal Children's Hospital Melbourne, Department of Plastic and Maxillofacial Surgery, Melbourne, Victoria, Australia; Murdoch Children's Research Institute, Vascular Biology Research Group and Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia; Monash University, Faculty of Medicine, Nursing, and Health Sciences, Melbourne, Victoria, Australia.
Background:
Infection in low flow malformations is difficult to diagnose and treat. Initial presentation can be followed by cycles of recurrent infection lasting several years. The optimal duration of antibiotic therapy to prevent recurrence of infection has not been established.
Methods:
All cases of infection in low flow malformations at the Royal Children's Hospital over a ten-year period were reviewed. Clinical markers of infection and duration of initial antibiotic treatment were correlated with the development of recurrent episodes of infection.
Results:
Twenty-one patients met criteria for inclusion. Nineteen were diagnosed as lymphatic malformations and two as venous malformations. The majority of patients (13 or 62%) received a prolonged course of six weeks or more of antibiotics. Eleven (52%) patients went on to have recurrent infections, but these were significantly less likely to be in those treated with a long course of antibiotics (Fisher's exact test, p=0.026). In only 12 of 21 cases could a bacterium be grown. Elevated CRP was the most consistent abnormal laboratory finding in infection.
Conclusions:
Longer courses of antibiotics reduce the risk of recurrent infection in low-flow vascular malformations. We recommend an antibiotic course of three months or more at the initial presentation of infection in a low flow malformation. Elevated CRP is the most sensitive test for diagnosis of infection in low-flow malformations.
Type Of Study:
Treatment study.
Level Of Evidence:
III.
Insights
Longer antibiotic courses for low-flow vascular malformations significantly reduce recurrent infections. A minimum of three months of antibiotics is recommended for initial infection treatment to prevent future episodes.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Pediatric Medicine
Background:
- Infection in low-flow malformations presents diagnostic and treatment challenges.
- Recurrent infections can persist for years, impacting patient health.
- Optimal antibiotic duration for preventing recurrence remains undefined.
Purpose of the Study:
- To investigate the correlation between antibiotic treatment duration and recurrent infections in low-flow malformations.
- To identify clinical and laboratory markers associated with infection in these malformations.
Main Methods:
- Retrospective review of patients with low-flow malformations and infection over ten years.
- Correlation analysis of initial antibiotic treatment duration with infection recurrence.
- Evaluation of clinical markers and C-reactive protein (CRP) levels.
Main Results:
- Twenty-one patients were included; 19 with lymphatic and 2 with venous malformations.
- Patients receiving longer antibiotic courses (≥6 weeks) had significantly fewer recurrent infections (p=0.026).
- Elevated CRP was the most consistent laboratory indicator of infection; bacteria were identified in only 12 cases.
Conclusions:
- Extended antibiotic therapy (≥3 months) is effective in reducing recurrent infections in low-flow vascular malformations.
- Elevated CRP is a sensitive diagnostic marker for infection in this patient group.
- A treatment course of three months or more is recommended for initial infections.
More Related Videos
10:31Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
06:18A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Related Concept Videos
Endocarditis III: Medical Management
Venous Thrombosis III: Interprofessional Care
Mitral Stenosis III: Medical Management
Endocarditis IV: Nursing Management
Hemodialysis I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management